Both microbiological surveillance and audit of procedures improve reprocessing of flexible bronchoscopes and patient safety.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 11 9 2021
medline: 25 10 2022
entrez: 10 9 2021
Statut: ppublish

Résumé

Microbiological surveillance of bronchoscopes and automatic endoscope reprocessors (AERs)/washer disinfectors as a quality control measure is controversial. Experts also are divided on the infection risks associated with bronchoscopic procedures. We evaluated the impact of routine microbiological surveillance and audits of cleaning/disinfection practices on contamination rates of reprocessed bronchoscopes. Audits were conducted of reprocessing procedures and microbiological surveillance on all flexible bronchoscopes used from January 2007 to June 2020 at a teaching hospital in France. Contamination rates per year were calculated and analyzed using a Poisson regression model. The risk factors for microbiological contamination were analyzed using a multivariable logistical regression model. In total, 478 microbiological tests were conducted on 91 different bronchoscopes and 57 on AERs. The rate of bronchoscope contamination significantly decreased between 2007 and 2020, varying from 30.2 to 0% ( Our results confirm that bronchoscopes can remain contaminated despite repeated reprocessing. Routine microbial testing of bronchoscopes for quality assurance and audit of decontamination and disinfection procedures can improve the reprocessing of bronchoscopes and minimize the rate of persistent contamination.

Sections du résumé

BACKGROUND
Microbiological surveillance of bronchoscopes and automatic endoscope reprocessors (AERs)/washer disinfectors as a quality control measure is controversial. Experts also are divided on the infection risks associated with bronchoscopic procedures.
OBJECTIVE
We evaluated the impact of routine microbiological surveillance and audits of cleaning/disinfection practices on contamination rates of reprocessed bronchoscopes.
DESIGN
Audits were conducted of reprocessing procedures and microbiological surveillance on all flexible bronchoscopes used from January 2007 to June 2020 at a teaching hospital in France. Contamination rates per year were calculated and analyzed using a Poisson regression model. The risk factors for microbiological contamination were analyzed using a multivariable logistical regression model.
RESULTS
In total, 478 microbiological tests were conducted on 91 different bronchoscopes and 57 on AERs. The rate of bronchoscope contamination significantly decreased between 2007 and 2020, varying from 30.2 to 0% (
CONCLUSIONS
Our results confirm that bronchoscopes can remain contaminated despite repeated reprocessing. Routine microbial testing of bronchoscopes for quality assurance and audit of decontamination and disinfection procedures can improve the reprocessing of bronchoscopes and minimize the rate of persistent contamination.

Identifiants

pubmed: 34503593
pii: S0899823X21003822
doi: 10.1017/ice.2021.382
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1466-1472

Auteurs

Philippe Saliou (P)

Infection Control Unit, Brest Teaching Hospital, Brest, France.
Univ Brest, Inserm, EFS, UMR 1078 GGB, F-29200 Brest, France.
Université de Bretagne Occidentale, Brest, France.

Lila Calmettes (L)

Infection Control Unit, Brest Teaching Hospital, Brest, France.
Université de Bretagne Occidentale, Brest, France.

Hervé Le Bars (H)

Department of microbiology, Brest Teaching Hospital, Brest, France.

Christopher Payan (C)

Univ Brest, Inserm, EFS, UMR 1078 GGB, F-29200 Brest, France.
Université de Bretagne Occidentale, Brest, France.
Department of microbiology, Brest Teaching Hospital, Brest, France.

Valérie Narbonne (V)

Department of microbiology, Brest Teaching Hospital, Brest, France.

Geneviève Héry-Arnaud (G)

Univ Brest, Inserm, EFS, UMR 1078 GGB, F-29200 Brest, France.
Université de Bretagne Occidentale, Brest, France.
Department of microbiology, Brest Teaching Hospital, Brest, France.

Elodie Moalic (E)

Department of microbiology, Brest Teaching Hospital, Brest, France.

Christophe Gut-Gobert (C)

Department of pneumology, Brest Teaching Hospital, France.

Raoul Baron (R)

Infection Control Unit, Brest Teaching Hospital, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH